Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer

Breast

Volumn 18, Issue 4, 2009, Pages 233-237

  Voguet, Laure ^a,b   Hébert, Thomas ^c   Levêque, Jean ^a,b   Acker, Olivier ^c   Mesbah, Habiba ^b   Marret, Henri ^c   Porée, Philippe ^a   Body, Gilles ^c  

^a Eugene Marquis Comprehensive Cancer Center   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c Olympe de Gouge Center   (France)

Author keywords

Breast cancer; Breast conserving therapy; Mastectomy; Residual tumor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 69949116810     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.06.002     Document Type: Article

References (35)

1. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 16 (2002) 1227-1232
2. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 16 (2002) 1233-1241
3. Blichert-Toft M., Nielsen M., During M., Moller S., Rank F., Overgaard M., et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 47 4 (2008) 672-681
4. Schnitt S.J. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?. Am J Clin Pathol 120 4 (2003) 485-488
5. Vennin P. Standards, Options and Recommendations (SOR) on hormone therapy in nonmetastatic cancer of the breast. Bull Cancer 87 12 (2000) 948-950
6. Cutuli B., Fourquet A., Luporsi E., Arnould L., Caron Y., Cremoux P., et al. Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004. Bull Cancer 92 2 (2005) 155-168
7. Papa M.Z., Zippel D., Koller M., Klein E., Chetrit A., and Ari G.B. Positive margins of breast biopsy: is reexcision always necessary?. J Surg Oncol 70 3 (1999) 167-171
8. Swanson G.P., Rynearson K., and Symmonds R. Significance of margins of excision on breast cancer recurrence. Am J Clin Oncol 25 5 (2002) 438-441
9. Cellini C., Huston T.L., Martins D., Christos P., Carson J., Kemper S., et al. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery. Am J Surg 189 6 (2005) 662-666
10. Sabel M.S., Rogers K., Griffith K., Jagsi R., Kleer C.G., Diehl K.A., et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol 99 2 (2009) 99-103
11. Tot T. The metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent. Hum Pathol 40 2 (2009) 199-205
12. Mirza N.Q., Vlastos G., Meric F., Buchholz T.A., Esnaola N., Singletary S.E., et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9 3 (2002) 256-265
13. Inaji H., Yanagisawa T., Komoike Y., Motomura K., and Koyama H. Wide excision as a method of breast-conserving surgery for breast cancer. Nippon Geka Gakkai Zasshi 103 11 (2002) 806-810
14. Leong C., Boyages J., Jayasinghe U.W., Bilous M., Ung O., Chua B., et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 100 9 (2004) 1823-1832
15. Huston T.L., and Simmons R.M. Locally recurrent breast cancer after conservation therapy. Am J Surg 189 2 (2005) 229-235
16. D'Halluin F., Tas P., Rouquette S., Bendavid C., Foucher F., Meshba H., et al. Intra-operative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures. Breast 18 4 (2009) 248-253
17. www.atih.sante.fr/
18. Smitt M.C., Nowels K.W., Zdeblick M.J., Jeffrey S., Carlson R.W., Stockdale F.E., et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76 2 (1995) 259-267
19. Singletary S.E. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184 5 (2002) 383-393
20. Aziz D., Rawlinson E., Narod S.A., Sun P., Lickley H.L., McCready D.R., et al. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 12 4 (2006) 331-337
21. Bollet M.A., Sigal-Zafrani B., Mazeau V., Savignoni A., de la Rochefordiere A., Vincent-Salomon A., et al. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Radiother Oncol 82 3 (2007) 272-280
22. Wazer D.E., Schmidt-Ullrich R.K., Ruthazer R., DiPetrillo T., Boyle T., Kanski J., et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 45 4 (1999) 885-891
23. Coulombe G., Tyldesley S., Speers C., Paltiel C., Aquino-Parsons C., Bernstein V., et al. Is mastectomy superior to breast-conserving treatment for young women?. Int J Radiat Oncol Biol Phys 67 5 (2007) 1282-1290
24. Gonzalez-Angulo A.M., Broglio K., Kau S.W., Eralp Y., Erlichman J., Valero V., et al. Women age < or =35 years with primary breast carcinoma: disease features at presentation. Cancer 103 12 (2005) 2466-2472
25. Hartley M.C., McKinley B.P., Rogers E.A., Kalbaugh C.A., Messich H.S., Blackhurst D.W., et al. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study. Am Surg 72 12 (2006) 1189-1194 [discussion: 1194-1195]
26. Zhou P., Gautam S., and Recht A. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat 101 1 (2007) 51-57
27. van der Leest M., Evers L., van der Sangen M.J., Poortmans P.M., van de Poll-Franse L.V., Vulto A.J., et al. The safety of breast-conserving therapy in patients with breast cancer aged < or =40 years. Cancer 109 10 (2007) 1957-1964
28. Horst K.C., Smitt M.C., Goffinet D.R., and Carlson R.W. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 5 6 (2005) 425-438
29. McIntosh A., Freedman G., Eisenberg D., and Anderson P. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am J Clin Oncol 30 2 (2007) 146-151
30. Jobsen J.J., Van Der Palen J., Ong F., and Meerwaldt J.H. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy. Acta Oncol 46 2 (2007) 172-180
31. Smitt M.C., Nowels K., Carlson R.W., and Jeffrey S.S. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 57 4 (2003) 979-985
32. Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 9453 (2005) 60-62
33. Dalberg K., Mattsson A., Rutqvist L.E., Johansson U., Riddez L., and Sandelin K. Breast conserving surgery for invasive breast cancer: risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 43 1 (1997) 73-86
34. Veronesi U., Luini A., Galimberti V., and Zurrida S. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 18 1 (1994) 70-75
35. Hartsell W.F., Recine D.C., Griem K.L., Cobleigh M.A., Witt T.R., and Murthy A.K. Should multicentric disease be an absolute contraindication to the use of breast-conserving therapy?. Int J Radiat Oncol Biol Phys 30 1 (1994) 49-53